Siekmann U, Heilmann L, Klosa W, Quaas L, Schillinger H
J Perinat Med. 1986;14(1):59-69. doi: 10.1515/jpme.1986.14.1.59.
In pre-eclampsia hemodynamic alterations are characterized by a lack of plasma volume expansion and a raised peripheral vascular resistance. For the compensation of plasma volume deficit and to restitute blood fluidity the therapeutic use of plasma volume expanders (f.e. low molecular dextran) is recommended. Several groups (Goodlin et al., Cloeren et al., Heilmann et al., Seghal et al., Schröck) have demonstrated benefitial effects on fetal status and development in the course of hypervolemic hemodilution in preeclampsia. This therapeutic procedure presumes the continuous surveillance of maternal hemodynamics to early recognize heart insufficiency or fluid overload in the lungs. We use the noninvasive thoracic impedance cardiography for continuous monitoring of maternal heart performance. The effect of hypervolemic hemodilution on fetal circulation has not been quantitatively investigated yet. Meanwhile pulsed doppler ultrasonography offers the possibility of estimating quantitative changes on fetal blood flow. We used both noninvasive techniques--thoracic impedance cardiography and pulsed doppler imaging system--for the simultaneous evaluation of maternal and fetal hemodynamic parameters during hypervolemic hemodilution. This preliminary report summarizes the investigations in 5 patients with pre-eclampsia (mean arterial blood pressure greater than or equal to 103.3 mm Hg, hemoconcentration with elevated hematocrit levels greater than or equal to 38%). The patients received an infusion of 500 ml dextran 40 over a period of exactly 60 minutes. The simultaneous measurements of maternal and fetal cardiovascular parameters were performed in 15-minutes intervals during dextran application and 15 minutes (p 15), 30 minutes (p 30) and 60 minutes (p 60) after the end of infusion.(ABSTRACT TRUNCATED AT 250 WORDS)
子痫前期的血流动力学改变表现为血浆容量无扩张以及外周血管阻力升高。为补偿血浆容量不足并恢复血液流动性,建议使用血浆容量扩充剂(如低分子右旋糖酐)进行治疗。多个研究小组(古德林等人、克洛伦等人、海尔曼等人、塞加尔等人、施罗克)已证明,子痫前期患者进行高血容量血液稀释过程中,对胎儿状况和发育有有益影响。该治疗方法需要持续监测母体血流动力学,以便早期识别心脏功能不全或肺部液体过载。我们使用无创胸阻抗心动图来持续监测母体心脏功能。高血容量血液稀释对胎儿循环的影响尚未进行定量研究。同时,脉冲多普勒超声检查提供了估计胎儿血流定量变化的可能性。我们使用无创技术——胸阻抗心动图和脉冲多普勒成像系统——在高血容量血液稀释期间同时评估母体和胎儿的血流动力学参数。本初步报告总结了对5例子痫前期患者(平均动脉血压大于或等于103.3毫米汞柱,血细胞比容水平升高导致血液浓缩大于或等于38%)的研究。患者在60分钟内精确输注500毫升右旋糖酐40。在输注右旋糖酐期间,每隔15分钟进行一次母体和胎儿心血管参数的同步测量,并在输注结束后15分钟(p 15)、30分钟(p 30)和60分钟(p 60)进行测量。(摘要截短于250字)